Online Forum

Sponsored by Bristol-Myers Squibb; Engage virtually with other Immuno-Oncology professionals from across the country and increase your knowledge of myositis, uveitis, thyroiditis and gastrointestinal toxicities secondary to immunotherapy. Previously described as “one of the best conferences I've attended and pitched perfectly so that I understood it!” book your place today to learn from “outstanding presentations” in a friendly and informative environment.

Practical Management of Immuno-Oncology (IO) Side Effects
Online 3 hours NHS Free

3 hours Continuing Professional Development: what you will learn

This morning online forum is an excellent opportunity to refresh your knowledge with a good balance between science, case studies and multi-professional learning. This dedicated forum will focus on:

  • Developing protocols and improving management of GI side effects
  • Triaging and treating inclusion body myositis (IBM)
  • Assessing and managing uveitis secondary to immunotherapy
  • Recognising and treating thyroiditis secondary to IO

Attend this online NHS event from the comfort of your own home

Packed with examples of best practice, novel ideas and expert advice, plus benefit from:

  • Meeting each other – turning on your videos and microphones in the breakout rooms
  • Listening and watching presentations and speakers’ Q&A – in the main conference room with your chair
  • Taking part in facilitated interactive sessions – enabled by moderators in the breakout rooms
  • Feeding back and engaging – using the chat box and moderators sharing content in the main conference room
9:00
Join, tech support and opportunity to network in breakout rooms
9:30
Introductions, instructions and chair’s opening remarks
Trudy Guinan, Immuno-Oncology Nurse Consultant , Clatterbridge Cancer Centre NHS Foundation Trust
Treating adverse effects
9:40
Developing protocols and improving management of GI side effects
  • Why do gastrointestinal toxicities present as side effects of immunotherapy?
  • Understanding the severity and when to escalate
  • Protocols to effectively manage toxicity: assessment, intervention, investigations and the MDT approach
Managing side effects
10:10
Assessing, triaging and treating inclusion body myositis (IBM)
  • Guidance for assessing symptoms: what to look out for and what to ask
  • Understanding when to escalate and when to initiate medication and rehabilitation
  • Case study examples: what lessons have been learnt?
10:40
Sponsored presentation from Bristol Myers Squib
10:45
Questions and answers with the speakers
10:55
Opportunity to meet Bristol Myers Squib in the breakout rooms
This is a great opportunity for you to pop-into dedicated breakout rooms to chat directly with Bristol Myers Squib or listen to presentations given by the team.
11:05
Screen break
11:15
Interactive discussion: Benchmark your experience of assessing and managing toxicities
  • What is your experience of managing immunotherapy toxicity?
  • How many patients receiving immunotherapy do you review each week?
  • How do you educate other professionals about side effects and toxicities of immunotherapy?
  • What escalation processes do you have in place in your team?
11:35
Feedback from interactive discussion on Benchmark your experience of assessing and managing toxicities
Identifying toxicities
11:45
Assessing and managing uveitis secondary to immunotherapy
  • Guidance for managing and treating immunotherapy induced inflammatory eye disease
  • Assessing the symptoms and initiating early and effective treatment
  • Learning from case study examples: what to look out for, when to investigate and when to initiate treatment
12:15
Recognising and treating thyroiditis secondary to IO
  • Assessing the symptoms and initiating early testing and diagnosis
  • Achieving timely referral and treatment of immunotherapy related thyroiditis
  • Learning from case study examples: what to look out for, when to investigate and when to initiate treatment
12:45
Questions and answers with the speakers
12:55
Chair’s closing remarks and close of online forum

Call for speakers

If you would like to give a presentation and share your work or the work of your service at this online conference, we would be delighted to hear from you. 

To discuss speaking opportunities please email the conference producer Hope Frost or call Hope on 01732 897788.

Your confirmed speakers to date:


Job Title:
Immuno-Oncology Nurse Consultant
Organisation
Clatterbridge Cancer Centre NHS Foundation Trust
Biography

Trudy-Jane Guinan has worked in the field of Oncology for over 18 years, working at The Clatterbridge Cancer Research Centre as an Advanced Nurse Practitioner and Lead Immunotherapy Nurse. During the past 3 and a half years she has worked with Medical Oncologist Dr Anna Olsson-Brown setting up the UK’s first Immuno-oncology service at the Cancer Centre, the service has received national recognition (Radio Interviews, ITV’s This morning, BBC Northwest piece) and won an award for innovation in the 2020 BJN Awards.  She regularly provides ongoing specialist support and advice to those involved in the delivery of IO across the country, speaks at National conferences and has run and presented at Immunotherapy workshops at Clatterbridge for national delegates as well as speaking at national conferences. Trudy has completed her Masters in Advanced Clinical Practice focusing her dissertation on the impact of a centralised IO service at the cancer centre, which has been accepted by the BJN for publication.  Following on from all her hard and dedication she has now been appointed as Nurse Consultant specialising in Immuno-oncology (the first in the UK).


Job Title:
Consultant Endocrinologist
Organisation
Chelsea and Westminster Hospital NHS Foundation Trust
Biography

Free NHS attendance

There are limited numbers for this online forum. Please cancel your place in writing if you can no longer attend. Non-attendance without written cancellation will result in £100 plus VAT charge.

Certification of attendance

A certificate for Continuing Professional Development will be given to every fully registered participant who completes the course, as a record of your continuing professional training and development.

Privacy notice

To view the details on how your data is being collected and used, please view our Privacy policy

Expected attendees

This online meeting is ideal for NHS professionals working in immunotherapy MDTs. This includes but is not limited to:

  • Lead Nurses, CNS, Matrons and Sisters in Cancer, Acute Oncology, Immunotherapy, Chemotherapy, CUP, Rapid Diagnostics and Haematology
  • Clinical Nurse Specialists and Consultants in Pain Management and Palliative Care
  • Consultant Clinical Oncologists, Consultant Medical Oncologists and Speciality Doctors
  • Pharmacists, Medical Managers and Service Managers

Past attendee feedback

Following 3 hugely successful online forums, this event will provide you and your team with useful updates and friendly, helpful interactive discussions – but don’t take our word for it! Take a look at how past attendees have described our immunotherapy online forums over the past 2 years:

“An excellent morning. Really enjoyed the balance between the (complex) science of checkpoint inhibitors and case studies that illustrated the importance of careful assessment and multi-professional working relationships.”

Somerset NHS Foundation Trust, Recognising and Treating IO Side Effects, November 2021

“Excellent, relevant, worthwhile and informative. The best online forum I have attended.”

University Hospitals Trust Sussex NHS Foundation Trust, Recognising and Treating IO Side Effects, November 2021

“Great session with experts who were knowledgeable and explained things very well.”

Worcester Acute NHS Trust, Recognising and Treating IO Side Effects, November 2021

“Excellent. One of the best I've attended. Pitched perfectly and I understood it!”

West Hertfordshire Hospitals NHS Trust, Recognising and Treating IO Side Effects, July 2021

“I found it very friendly, and very informative. It was nice to talk to other areas before the presentations started in small groups and learn a bit about how other areas process are for triage and assessment of their patients.”

Sheffield Teaching Hospitals NHS Foundation Trust, Recognising and Treating IO Side Effects, July 2021

“I am so grateful for the knowledge acquired through my first virtual conference. It was very well organised with technical support provided, very efficient. Speakers were excellent and content very appropriate and relevant.”

Royal Surrey NHS Foundation Trust, Managing Side Effects of Cancer Immunotherapy, December 2020

“Informative, friendly and highly appropriate content. Really exciting day as it felt like networking and being present at a physical conference, so thank you for making it so warm and welcoming.”

Western Sussex Hospitals NHS Trust, Managing Side Effects of Cancer Immunotherapy, December 2020

View further comments on SBK Healthcare events on Trust Pilot.